Lexicon Pharmaceuticals Inc. Resources | BNET
On The Insider: Sexy Aussie Babes

BNET Industries

Lexicon Pharmaceuticals Inc. (LXRX) is in the Pharma Industry

Revenue
Dec 31 2007
$50.1M
Profit
Dec 31 2007
($58.7M)
Market Cap
Sep 04 2008
$246.2M

Latest News and Analysis

Additional Resources

  • BioSeek Initiates Research Collaboration With Lexicon Pharmaceuticals

    BURLINGAME, Calif. -- BioSeek, Inc., a pioneer in applying predictive human biology systems to drug discovery and development, announced today the initiation of a research collaboration with Lexicon Pharmaceuticals, Inc. Under the agreement, BioSeek's BioMAP[R] Systems will be used to help further evaluate selected compounds associated with several of Lexicon's...

    Articles 2008-04-29

  • Hot Stock Alert for Tuesday March 18, 2008.

    M2 PRESSWIRE-18 March 2008-AnalystStockReport.com: Hot Stock Alert for Tuesday March 18, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:18032008 Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), KENDLE INTL INC (Nasdaq: KNDL), INCA DESIGNS, INC. (PinkSheets: IDGI), BodyTel Scientific Inc. (OTC BB:BDYT) ,...

    Articles 2008-03-18

  • Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008

    Conference Call and Webcast to Follow THE WOODLANDS, Texas, Feb. 20 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. will release its fourth quarter and year end 2007 financial results on Thursday, March 6, 2008 after the financial markets close. Lexicon management will hold a conference call to...

    Articles 2008-02-20

  • Zacks Analyst Interview Highlights: Amgen, GlaxoSmithKline and Lexicon Pharmaceuticals

    CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Grant Zeng, who discusses Amgen (Nasdaq: AMGN), GlaxoSmithKline (NYSE: GSK) and Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX). A synopsis of today's Analyst Interview is presented below. The full article can be read at www.zacks.com. ...

    Articles 2007-12-03

  • Sequenom Reports Third Quarter 2007 Financial Results

    Completes $30 Million Private Placement Conference Call Begins Today at 4:30 p.m. Eastern Time SAN DIEGO -- Sequenom, Inc. (NASDAQ:SQNM) today reported financial results for the three and nine months ended September 30, 2007. The Company also announced completion of the previously announced...

    Articles 2007-10-31

  • BIO Investor Forum 2007 Conference Provides Insights Into Investment Pipeline

    WASHINGTON -- The Biotechnology Industry Organization BIO today announced the moderators and panelists delivering the opening plenary session, Check Your Options: Raising Public and Private Financing in Today's Marketplace, at the BIO Investor Forum 2007. The conference will take place October 9-11, at the Palace Hotel in...

    Articles 2007-10-03

  • Zacks Analyst Interview Highlights: Lexicon Pharmaceuticals, Critical Therapeutics and Sangamo Biosciences

    CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Grant Zeng, who discusses Lexicon Pharmaceuticals (Nasdaq: LEXG), Critical Therapeutics (Nasdaq: CRTX) and Sangamo Biosciences (Nasdaq: SGMO). A synopsis of today's Analyst Interview is presented below. The full article can be...

    Articles 2007-08-23

  • BioLineRx Adds Three Industry Experts to Its Board of Directors

    JERUSALEM -- BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, announced today that Tamar Howson, Gil Bianco and Ilan Leviteh have been appointed to the Company's board of directors. Ms. Howson brings to BioLineRx more than 20 years of pharmaceutical and biotech industry experience. Ms....

    Articles 2007-08-07

  • Lexicon Pharmaceuticals, Inc Announces Potential New Therapy.

    M2 PRESSWIRE-4 July 2007-FINANCIALS: Lexicon Pharmaceuticals, Inc Announces Potential New TherapyC1994-2007 M2 COMMUNICATIONS LTD RDATE:05072007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a ...

    Articles 2007-07-04

  • Friday's Featured Stock: nCoat, Inc. (OTCBB: NCOA).

    M2 PRESSWIRE-4 July 2007-SmallCapStockAnalyst.com: Friday's Featured Stock: nCoat, Inc. (OTCBB: NCOA)C1994-2007 M2 COMMUNICATIONS LTD RDATE:06072007 Stocks to Watch: nCoat, Inc. (OTCBB: NCOA), Sharper Image Corporation (Nasdaq:SHRP) , Who's Your Daddy, Inc. (OTC BB:WYDY), Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) , Diomed Holdings,...

    Articles 2007-07-04

  • Market Commentary on Lexicon Pharmaceuticals, Inc.

    M2 PRESSWIRE-3 July 2007-Biotech News: Market Commentary on Lexicon Pharmaceuticals, IncC1994-2007 M2 COMMUNICATIONS LTD RDATE:03072007 Market Commentary on Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of pharmaceutical products for the...

    Articles 2007-07-03

  • Zacks Analyst Interview Highlights: Sangamo Bioscience, Lexicon Pharmaceuticals and Critical Therapeutics

    CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Grant Zeng, who discusses Sangamo Bioscience (Nasdaq: SGMO), Lexicon Pharmaceuticals (Nasdaq: LXRX) and Critical Therapeutics (Nasdaq: CRTX). A synopsis of today's Analyst Interview is presented below. The full article can be read at http://at.zacks.com/?id=2678....

    Articles 2007-07-03

  • Kathleen M. Wiltsey Named to Sequenom Board of Directors

    SAN DIEGO -- Sequenom, Inc. (NASDAQ:SQNM) today announced that Kathleen M. Wiltsey has been elected to the Company's board of directors. "Kathleen brings significant biotechnology commercialization experience to Sequenom and we plan to call upon her experience in launching and marketing two leading biotechnology products...

    Articles 2007-06-26

  • nCoat Signs Definitive Agreement to Acquire Metallic Ceramic Coatings, Inc.

    M2 PRESSWIRE-20 June 2007-SmallCapStockAnalyst.com: nCoat Signs Definitive Agreement to Acquire Metallic Ceramic Coatings, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:20062007 Stocks to Watch: nCoat, Inc. (OTCBB: NCOA), Far East Energy Corp. (OTCBB: FEEC), LMI Aerospace Inc. (Nasdaq:LMIA) , Patriot Scientific Corporation (OTCBB:...

    Articles 2007-06-20

  • Open Energy (OTCBB: OEGY) Receives Price Target of $1.25.

    M2 PRESSWIRE-20 June 2007-LiquidStockReport.com: Open Energy (OTCBB: OEGY) Receives Price Target of $1.25C1994-2007 M2 COMMUNICATIONS LTD RDATE:20062007 Stocks to Watch: Open Energy Corporation (OTCBB: OEGY) , Far East Energy Corp. (OTCBB: FEEC), LMI Aerospace Inc. (Nasdaq:LMIA) , Patriot Scientific Corporation...

    Articles 2007-06-20

  • page 1 of 1
  • Incorporated: 1995
  • CEO: Dr. Arthur T. Sands Ph.D.

Lexicon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of treatments for human disease. Co. utilizes its proprietary gene knockout technology to discover the physiological and behavioral functions and utility of the proteins encoded by the corresponding human genes as potential drug targets. As of Dec 31 2007, Co.'s product candidates include LX6171, for the potential treatment for cognitive impairment, LX1031, for the potential treatment for gastrointestinal disorders, LX1032, for the potential treatment for carcinoid syndrome, and LX2931, for the potential treatment for autoimmune diseases such as rheumatoid arthritis.

Key Competitors

advertisement
Lexicon Pharmaceuticals Inc. Company Info

Board of Directors

Dr. Samuel L. Barker Ph.D.

Chairman

Mr. Frank P. Palantoni

Dr. Arthur T. Sands Ph.D.

Mr. Christopher J. Sobecki

Dr. Judith L. Swain

Ms. Kathleen M. Wiltsey

Mr. Philippe J. Amouyal

Mr. Raymond Debbane

Dr. Robert J. Lefkowitz M.D.

Dr. Alan S. Nies M.D.

Contact Information

8800 Technology Forest Place

The Woodlands, TX

http://www.lexicon-genetics.com

281 863-3000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement